GluR-5 Polyclonal Antibody

Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. The subunit encoded by this gene is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to alter the properties of ion flow. Alternative splicing, resulting in transcript variants encoding different isoforms, has been noted for GRIK1.

The GluR-5 Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to detect and quantify the GluR-5 protein in various biological samples. This antibody has been extensively validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The GluR-5 Polyclonal Antibody has been produced using high-quality materials and state-of-the-art techniques to ensure maximum specificity and sensitivity. It has been purified using a combination of affinity chromatography and ion exchange chromatography to remove any non-specific binding and impurities.

This antibody has been extensively tested for cross-reactivity with other proteins and has been shown to be highly specific for the GluR-5 protein. It has also been shown to be highly sensitive, with a detection limit of as low as 0.1 ng/mL.

The GluR-5 Polyclonal Antibody is supplied in a convenient and easy-to-use format, with a range of sizes available to suit your specific needs. It is also supplied with detailed instructions for use, including recommended dilutions and storage conditions.

Overall, the GluR-5 Polyclonal Antibody is a highly reliable and effective tool for the detection and quantification of the GluR-5 protein in a wide range of biological samples. Its high specificity and sensitivity make it an ideal choice for researchers and scientists working in the fields of neuroscience, pharmacology, and drug discovery.